Myofibroblast-mediated mechanisms of pathological remodelling of the heart

KT Weber, Y Sun, SK Bhattacharya… - Nature Reviews …, 2013 - nature.com
The syncytium of cardiomyocytes in the heart is tethered within a matrix composed
principally of type I fibrillar collagen. The matrix has diverse mechanical functions that …

Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment

BA Borlaug, WJ Paulus - European heart journal, 2011 - academic.oup.com
Half of patients with heart failure (HF) have a preserved left ventricular ejection fraction
(HFpEF). Morbidity and mortality in HFpEF are similar to values observed in patients with HF …

Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies

BC Bernardo, KL Weeks, L Pretorius… - Pharmacology & …, 2010 - Elsevier
Cardiac hypertrophy can be defined as an increase in heart mass. Pathological cardiac
hypertrophy (heart growth that occurs in settings of disease, eg hypertension) is a key risk …

[HTML][HTML] Epidemiology and pathogenesis of heart failure with preserved ejection fraction

N Nair - Reviews in cardiovascular medicine, 2020 - imrpress.com
Heart failure (HF) is a complex syndrome that affects approximately 6.5 million adults in the
United States. About half of the 6.5 million adults with HF are estimated to be individuals with …

Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI

PJ Basser, C Pierpaoli - Journal of magnetic resonance, 2011 - Elsevier
Quantitative-diffusion-tensor MRI consists of deriving and displaying parameters that
resemble histological or physiological stains, ie, that characterize intrinsic features of tissue …

Molecular mechanisms of myocardial remodeling

B Swynghedauw - Physiological reviews, 1999 - journals.physiology.org
Swynghedauw, Bernard. Molecular Mechanisms of Myocardial Remodeling. Physiol. Rev.
79: 215–262, 1999.—“Remodeling” implies changes that result in rearrangement of …

Mechanisms and models in heart failure: the biomechanical model and beyond

DL Mann, MR Bristow - Circulation, 2005 - Am Heart Assoc
resultant striking increase in morbidity and mortality. The transition to symptomatic heart
failure is accompanied by further activation of neurohormonal and cytokine systems, as well …

TGF-β1 and angiotensin networking in cardiac remodeling

S Rosenkranz - Cardiovascular research, 2004 - academic.oup.com
The renin–angiotensin system (RAS) and transforming growth factor-β1 (TGF-β1) play a
pivotal role in the development of cardiac hypertrophy and heart failure. Recent studies …

Transforming growth factor-β function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats

F Kuwahara, H Kai, K Tokuda, M Kai, A Takeshita… - Circulation, 2002 - Am Heart Assoc
Background—Excessive myocardial fibrosis impairs cardiac function in hypertensive hearts.
Roles of transforming growth factor (TGF)-β in myocardial remodeling and cardiac …

Aldosterone in congestive heart failure

KT Weber - New England Journal of Medicine, 2001 - Mass Medical Soc
The potent mineralocorticoid aldosterone has a multifaceted role in the pathogenesis of
congestive heart failure. In addition to its contribution to salt and water retention, it also …